| Analysis of Circulating Tumor DNA Predicts Outcomes of Short Course Consolidation Immunotherapy in Unresectable Stage III Non-Small Cell Lung Cancer S Jun, NA Shukla, G Durm, AB Hui, S Cao, AK Ganti, SK Jabbour, ... Journal of Thoracic Oncology, 2024 | | 2024 |
| Chest wall pain after single-fraction thoracic stereotactic ablative Radiotherapy: Dosimetric analysis from the iSABR trial B Lau, YF Wu, S Cui, J Fu, S Jackson, D Pham, P Dubrowski, ... Radiotherapy and Oncology 196, 110317, 2024 | | 2024 |
| Assessing the Evidence for Circulating Tumor HPV DNA in Patients With Oropharyngeal Cancer NY Lee, LGT Morris, M Diehn JAMA oncology, 2024 | | 2024 |
| Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients D Mathew, ME Marmarelis, C Foley, JM Bauml, D Ye, R Ghinnagow, ... Science 384 (6702), eadf1329, 2024 | 3 | 2024 |
| Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy MP Hamilton, T Sugio, T Noordenbos, S Shi, PL Bulterys, CL Liu, X Kang, ... New England Journal of Medicine 390 (22), 2047-2060, 2024 | 4 | 2024 |
| A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease. HA Yu, MF Chen, AB Hui, NJ Choudhury, JJK Lee, J Zheng, LSH Ahn, ... Journal of Clinical Oncology 42 (16_suppl), 8517-8517, 2024 | | 2024 |
| Use of artificial intelligence–based digital pathology to predict outcomes for immune checkpoint inhibitor therapy in advanced gastro-esophageal cancer. F Eweje, Z Li, M Gopaulchan, A Attaranzadeh, L Kloker, Y Jiang, M Diehn, ... Journal of Clinical Oncology 42 (16_suppl), 4013-4013, 2024 | | 2024 |
| Ultrasensitive circulating tumor DNA (ctDNA) minimal residual disease (MRD) detection in early stage non-small cell lung cancer (NSCLC). JM Isbell, JS Goldstein, EG Hamilton, SY Liu, JE Eichholz, DJ Buonocore, ... Journal of Clinical Oncology 42 (16_suppl), 8078-8078, 2024 | | 2024 |
| Methods and Systems for Analyzing Nucleic Acid Molecules DM Kurtz, M Diehn, AA Alizadeh US Patent App. 18/435,880, 2024 | | 2024 |
| Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis TD Azad, S Nanjo, MC Jin, JJ Chabon, DM Kurtz, AA Chaudhuri, ... NPJ Precision Oncology 8 (1), 121, 2024 | | 2024 |
| System and method for gene expression and tissue of origin inference from cell-free dna M Diehn, AA Alizadeh, M Mehrmohamadi, MS Esfahani US Patent App. 17/980,254, 2024 | | 2024 |
| MP71-19 ULTRASENSITIVE URINARY LIQUID BIOPSY ANALYSIS FOR BCG RESPONSE ASSESSMENT IN HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER WY Shi, KJ Liu, MS Esfahani, JG Schroers-Martin, M Nesselbush, ... The Journal of Urology 211 (5S), e1169, 2024 | | 2024 |
| Methods and systems for analyzing nucleic acid molecules DM Kurtz, M Diehn, AA Alizadeh US Patent 11,965,215, 2024 | | 2024 |
| First in Human Phase 1 Clinical Trial of Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) in Severe Emphysema DN Kamtam, MS Binkley, N Kapula, C Sadeghi, S Nesbit, HH Guo, ... International Journal of Radiation Oncology* Biology* Physics, 2024 | 1 | 2024 |
| Methods and Systems for Analyzing Nucleic Acid Molecules JJ Chabon, DM Kurtz, M Diehn, AA Alizadeh US Patent App. 18/452,463, 2024 | | 2024 |
| Cancer biomarkers: Emerging trends and clinical implications for personalized treatment A Passaro, M Al Bakir, EG Hamilton, M Diehn, F André, S Roy-Chowdhuri, ... Cell 187 (7), 1617-1635, 2024 | 9 | 2024 |
| Cell-free RNA analysis for non-invasive cancer detection and characterization MC Nesselbush, BA Luca, YJ Jeon, I Jabara, CB Meador, MS Binkley, ... Cancer Research 84 (6_Supplement), 6560-6560, 2024 | | 2024 |
| Saturation mutagenesis of KEAP1 to identify pathogenic mutations in lung cancer patients and gain insight into KEAP1 molecular function N Kastelowitz, S Shrishrimal, S Jun, AM Zhang, R Wang, I Ilerten, M Diehn Cancer Research 84 (6_Supplement), 377-377, 2024 | | 2024 |
| Improved cfDNA methylation profiling through correction of misrepaired jagged-ends R Wang, EG Hamilton, D Almanza, A Hui, M Diehn, AA Alizadeh Cancer Research 84 (6_Supplement), 960-960, 2024 | | 2024 |
| Highly accurate profiling of leukocyte composition from bulk peripheral blood with targeted digital cytometry A Nakao, AM Newman, AA Alizadeh, M Diehn, M Ghosh, M Aliminati, ... Cancer Research 84 (6_Supplement), 4898-4898, 2024 | | 2024 |
Ash A. Alizadeh, MD, PhDStanford University, Moghadam Family Professor of Medicine在 stanford.edu 的电子邮件经过验证
